NCT02331706 2020-04-21IFN-DLI for Relapsed Acute Leukemia After Allo-SCTAbramson Cancer Center at Penn MedicinePhase EARLY_PHASE1 Completed16 enrolled
NCT00548847 2016-10-26Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic TransplantationEmory UniversityPhase 2 Completed15 enrolled 9 charts